On August 31, 2026, the Securities and Exchange Commission (SEC) and the Food and Drug Administration (FDA) announced a groundbreaking Memorandum of Understanding (MOU) designed to formalize and accelerate the exchange of nonpublic information between the two agencies. While the announced goal is broad—“ensuring the integrity of the financial markets and protecting public health”—the practical...Read More